Skip to content

Impact of Propofol Reduction in Anesthesia Induction

Impact of Propofol Dose Reduction in Relation to the Time Since Administration of Fentanyl During Anesthesia Induction

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04194151
Enrollment
192
Registered
2019-12-11
Start date
2017-11-01
Completion date
2018-10-26
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol Adverse Reaction, Anesthesia

Keywords

propofol synergy, fentanyl, anesthesia induction

Brief summary

Objective: Determine if, by reducing the dose of propofol and increasing the time elapsed between fentanyl and propofol administration, hemodynamic response is improved. Methods: Patients were randomized into time groups (2 and 1 minute) and each subdivided into dose groups (1, 1.5 and 2 mg kg-1) obtaining six time-dose groups. After receiving 2 μg kg-1 of fentanyl, propofol was administered after the predetermined time. Time to hypnosis (BIS\<60) and hemodynamic parameters at pre-induction, pre-intubation and postintubation were registered.

Detailed description

A minimum of 162 patients were required, considering an expected Mean Difference of 5 with expected Standard Deviation of 22, confidence level of 95% and power of 80%. Estimating a possible loss of 15%, it was raised to 192. Consecutive identification numbers were assigned and the sample was randomized in six groups of 32 patients according to time and dose of propofol. Pre-oxygenation was performed until the expired oxygen fraction exceeded 80% and 2 µg/kg of intravenous fentanyl were administered. Depending on the study group, 1 or 2 minutes were allowed to pass and 1, 1.5 or 2 mg/kg of propofol were supplied (prior administration of intravenous lidocaine 0.5 mg/kg). The time in which the BIS dropped below 60 was recorded. If it did not reach that level after two minutes or when it exceeded it but then rose above 60 again, an extra dose of propofol of 0.5 mg/kg was administered. Muscle relaxation was performed with rocuronium 0.6 mg/kg. The patient was manually ventilated until endotracheal intubation was performed by the same experienced anaesthesiologist and connected to mechanical ventilation. Data were collected manually. Statistical analysis was performed using SPSS ver. 22. Inferential statistics were performed using t-test for quantitative variables, chi-square for qualitative and ANOVA for qualitative and quantitative comparisons. Non-parametric statistical tests were used when necessary. Confidence intervals were estimated at a level of 95% and a P value of \<.05 was considered statistically significant.

Interventions

1, 1.5 or 2 mg/kg of propofol according to the subgroup

Sponsors

Hospital Central de la Defensa Gómez Ulla
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

aleatory assignation, time measured by nurses, drugs administrated by principal investigator

Intervention model description

2 time groups, divided into 3 dose groups

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults who required general anesthesia * General anesthesia with endotracheal intubation (no supraglottic devices) * Signed informed consent * Non-cardiac surgery * Same anesthesiologist

Exclusion criteria

* Hemodynamic instability (systolic BP \< 90 mmHg with clinical signs of low cardiac output: impaired consciousness, diuresis \<0.5 ml/kg/h, central venous saturation \<60% with normal arterial saturation or lactate \>3 mmol/l) * Increased risk of bronchoaspiration (absence of fasting, stomach retention, intestinal obstruction, pregnancy, etc.) * Suspected difficult airway * Known allergy to anesthetic drugs

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood Pressure VariationBaseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positionedNon-invasive systolic blood pressure change (%) at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.
Heart Rate VariationBaseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positionedHeart rate change (%) registered at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in HR between the studied moments. Negative results mean percentage increase in HR between the studied moments.
Systolic Blood Pressure Variation in Elderly (>55y)Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positionedNon-invasive SBP change (%) in patients \> 55 years at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.

Secondary

MeasureTime frameDescription
Time to HypnosisAfter administration of propofol, time is measured in seconds until BIS values are less than 60Bispectral index (BIS)\<60 meaning general anesthesia, BIS\>60 meaning mild/moderate sedation. We measure the time until patient reachs hypnosis
Number of Patients Who Needed Vasoactive Drug1 minute after intubationPatients who suffered SPB reduction \> 30% or SPB \< 90mmHg, receive vasoactive drugs

Countries

Spain

Participant flow

Recruitment details

Every patient who agreed to participate and required general anesthesia with endotracheal intubation by the same anesthesiologist

Pre-assignment details

Randomization was prior to data collection. The patient number was assigned by computerized randomizer to the 6 study groups. The collection was systematic from day one of the study, including all patients who met inclusion criteria and accepted participation. Of 192 patients enrolled, 186 met inclusion criteria.

Participants by arm

ArmCount
2 Minute - 2 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 2 mg/kg of propofol
31
2 Minute - 1,5 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 1,5 mg/kg of propofol
30
2 Minute - 1 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 1 mg/kg of propofol
31
1 Minute - 2 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 2 mg/kg of propofol
31
1 Minute - 1,5 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 1,5 mg/kg of propofol
32
1 Minute - 1 mg/kg Group
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 1 mg/kg of propofol
31
Total186

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005
Overall StudyMonitorization problem010000
Overall StudyPhysician Decision111101

Baseline characteristics

Characteristic2 Minute - 2 mg/kg Group2 Minute - 1,5 mg/kg Group2 Minute - 1 mg/kg Group1 Minute - 2 mg/kg Group1 Minute - 1,5 mg/kg Group1 Minute - 1 mg/kg GroupTotal
Age, Continuous59 years
STANDARD_DEVIATION 20
61 years
STANDARD_DEVIATION 17
60 years
STANDARD_DEVIATION 19
59 years
STANDARD_DEVIATION 17
64 years
STANDARD_DEVIATION 18
55 years
STANDARD_DEVIATION 16
60 years
STANDARD_DEVIATION 18
anesthesia risk (ASA), categorical
High risk
11 Participants11 Participants14 Participants10 Participants19 Participants10 Participants75 Participants
anesthesia risk (ASA), categorical
Low risk
20 Participants19 Participants17 Participants21 Participants13 Participants21 Participants111 Participants
Antihypertensive treatment9 Participants9 Participants12 Participants10 Participants12 Participants11 Participants63 Participants
Heart rate treatment11 Participants7 Participants10 Participants9 Participants11 Participants3 Participants51 Participants
Hypertension15 Participants9 Participants15 Participants13 Participants16 Participants13 Participants81 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
15 Participants14 Participants17 Participants17 Participants18 Participants14 Participants95 Participants
Sex: Female, Male
Male
16 Participants16 Participants14 Participants14 Participants14 Participants17 Participants91 Participants
weight73 kilograms
STANDARD_DEVIATION 16
77 kilograms
STANDARD_DEVIATION 17
70 kilograms
STANDARD_DEVIATION 15
71 kilograms
STANDARD_DEVIATION 15
71 kilograms
STANDARD_DEVIATION 15
73 kilograms
STANDARD_DEVIATION 15
72 kilograms
STANDARD_DEVIATION 15

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
deaths
Total, all-cause mortality
0 / 310 / 300 / 310 / 310 / 320 / 31
other
Total, other adverse events
4 / 311 / 300 / 312 / 313 / 320 / 31
serious
Total, serious adverse events
0 / 310 / 300 / 310 / 310 / 320 / 31

Outcome results

Primary

Heart Rate Variation

Heart rate change (%) registered at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in HR between the studied moments. Negative results mean percentage increase in HR between the studied moments.

Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned

ArmMeasureGroupValue (MEAN)Dispersion
2 Minute - 2 mg/kg GroupHeart Rate VariationHR baseline/postintubation-10 percentage of variationStandard Deviation 19
2 Minute - 2 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation6 percentage of variationStandard Deviation 13
2 Minute - 2 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-17 percentage of variationStandard Deviation 19
2 Minute - 1,5 mg/kg GroupHeart Rate VariationHR baseline/postintubation-8 percentage of variationStandard Deviation 15
2 Minute - 1,5 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation4 percentage of variationStandard Deviation 8
2 Minute - 1,5 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-12 percentage of variationStandard Deviation 16
2 Minute - 1 mg/kg GroupHeart Rate VariationHR baseline/postintubation-9 percentage of variationStandard Deviation 16
2 Minute - 1 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation4 percentage of variationStandard Deviation 10
2 Minute - 1 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-15 percentage of variationStandard Deviation 20
1 Minute - 2 mg/kg GroupHeart Rate VariationHR baseline/postintubation-4 percentage of variationStandard Deviation 17
1 Minute - 2 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation1 percentage of variationStandard Deviation 11
1 Minute - 2 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-5 percentage of variationStandard Deviation 16
1 Minute - 1,5 mg/kg GroupHeart Rate VariationHR baseline/postintubation-5 percentage of variationStandard Deviation 20
1 Minute - 1,5 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation4 percentage of variationStandard Deviation 15
1 Minute - 1,5 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-10 percentage of variationStandard Deviation 19
1 Minute - 1 mg/kg GroupHeart Rate VariationHR baseline/pre-intubation5 percentage of variationStandard Deviation 14
1 Minute - 1 mg/kg GroupHeart Rate VariationHR pre-intubation/postintubation-17 percentage of variationStandard Deviation 19
1 Minute - 1 mg/kg GroupHeart Rate VariationHR baseline/postintubation-10 percentage of variationStandard Deviation 18
Primary

Systolic Blood Pressure Variation

Non-invasive systolic blood pressure change (%) at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.

Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned

ArmMeasureGroupValue (MEAN)Dispersion
2 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation11 percentage of variationStandard Deviation 22
2 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation26 percentage of variationStandard Deviation 16
2 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-22 percentage of variationStandard Deviation 27
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation8 percentage of variationStandard Deviation 15
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation23 percentage of variationStandard Deviation 12
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-21 percentage of variationStandard Deviation 28
2 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation9 percentage of variationStandard Deviation 19
2 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation18 percentage of variationStandard Deviation 13
2 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-12 percentage of variationStandard Deviation 17
1 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation14 percentage of variationStandard Deviation 18
1 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation22 percentage of variationStandard Deviation 11
1 Minute - 2 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-12 percentage of variationStandard Deviation 21
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation16 percentage of variationStandard Deviation 19
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation18 percentage of variationStandard Deviation 13
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-3 percentage of variationStandard Deviation 16
1 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/pre-intubation17 percentage of variationStandard Deviation 13
1 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP pre-intubation/postintubation-12 percentage of variationStandard Deviation 16
1 Minute - 1 mg/kg GroupSystolic Blood Pressure VariationSBP baseline/postintubation8 percentage of variationStandard Deviation 16
Primary

Systolic Blood Pressure Variation in Elderly (>55y)

Non-invasive SBP change (%) in patients \> 55 years at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.

Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned

ArmMeasureGroupValue (MEAN)Dispersion
2 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation19 percentage of variationStandard Deviation 22
2 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation36 percentage of variationStandard Deviation 12
2 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation-27 percentage of variationStandard Deviation 32
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation10 percentage of variationStandard Deviation 14
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation26 percentage of variationStandard Deviation 12
2 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation-23 percentage of variationStandard Deviation 30
2 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation13 percentage of variationStandard Deviation 19
2 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation21 percentage of variationStandard Deviation 13
2 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation-10 percentage of variationStandard Deviation 16
1 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation22 percentage of variationStandard Deviation 15
1 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation29 percentage of variationStandard Deviation 6
1 Minute - 2 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation-10 percentage of variationStandard Deviation 23
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation22 percentage of variationStandard Deviation 17
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation21 percentage of variationStandard Deviation 13
1 Minute - 1,5 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation2 percentage of variationStandard Deviation 13
1 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/pre-intubation22 percentage of variationStandard Deviation 13
1 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP pre-intubation/postintubation-15 percentage of variationStandard Deviation 19
1 Minute - 1 mg/kg GroupSystolic Blood Pressure Variation in Elderly (>55y)SBP baseline/postintubation12 percentage of variationStandard Deviation 13
Secondary

Number of Patients Who Needed Vasoactive Drug

Patients who suffered SPB reduction \> 30% or SPB \< 90mmHg, receive vasoactive drugs

Time frame: 1 minute after intubation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
2 Minute - 2 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug4 Participants
2 Minute - 1,5 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug1 Participants
2 Minute - 1 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug0 Participants
1 Minute - 2 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug2 Participants
1 Minute - 1,5 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug3 Participants
1 Minute - 1 mg/kg GroupNumber of Patients Who Needed Vasoactive Drug0 Participants
Secondary

Time to Hypnosis

Bispectral index (BIS)\<60 meaning general anesthesia, BIS\>60 meaning mild/moderate sedation. We measure the time until patient reachs hypnosis

Time frame: After administration of propofol, time is measured in seconds until BIS values are less than 60

ArmMeasureValue (MEAN)Dispersion
2 Minute - 2 mg/kg GroupTime to Hypnosis54 secondsStandard Deviation 29
2 Minute - 1,5 mg/kg GroupTime to Hypnosis49 secondsStandard Deviation 27
2 Minute - 1 mg/kg GroupTime to Hypnosis62 secondsStandard Deviation 34
1 Minute - 2 mg/kg GroupTime to Hypnosis41 secondsStandard Deviation 20
1 Minute - 1,5 mg/kg GroupTime to Hypnosis47 secondsStandard Deviation 15
1 Minute - 1 mg/kg GroupTime to Hypnosis67 secondsStandard Deviation 42

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026